New Report Explores Hottest Trends in Covid-19 Vaccine Market 2020-2025: Global Key Vendors - Moderna, GSK, Inovio Pharma, Zydus Cadila, Codagenix, GeoVax, Bravovax, CanSino Biologics

Global Covid-19 Vaccine Market Synopsis:

The exclusive research report on the Global Covid-19 Vaccine Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Covid-19 Vaccine Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

According to the global medical news, Scientists on Monday gave the first-ever injection of an experimental coronavirus vaccine to volunteers in the US.

Doses of mRNA-1273 into the arms of healthy participants at Kaiser Permanente Washington Research Institute (KPWHRI) this week began the first-stage study of a potential COVID-19 immunization. The initial trial involves 45 people aged 18 to 55, including tech company operations manager Jennifer Haller-the study's first participant.

"We all feel so helpless. This is an amazing opportunity for me to do something," the 43-year-old Seattelite told the Associated Press before getting jabbed. She reportedly left the exam room with a smile, "feeling great."

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/253572 .

Significant points in table of contents: Market Definition, Market Overview, Business Introduction, Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation (Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost Analysis, and Conclusion. The Covid-19 Vaccine Market is segmented based on Product, source, application and Regions. On the basis of product, the market is sub-segmented.

Regionally, North America and Europe holds major share in Global Covid-19 Vaccine Market. Moreover, Asia-Pacific is expected to record higher growth rate in Covid-19 Vaccine market during the forecast year.

Top Major Key Players in the Global Covid-19 Vaccine Market:

1 Inovio Pharmaceuticals

2 Takis Biotech (Evvivax)

3 Zydus Cadila

4 Codagenix

5 GeoVax

6 Bravovax

7 Janssen Pharmaceutical Companies

8 Altimmune

9 Vaxart

10 CanSino Biologics

11 ExpreS2ion Biotechnologies ApS

12 Clover Biopharmaceuticals

13 GSK

14 Vaxil Bio

15 Generex

16 Novavax

17 Sanofi Pasteur

18 Baylor

19 iBio

20 Moderna

21 Curevac

22 ImmunoPrecise and More...............

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Covid-19 Vaccine Market Report 2020" @ https://www.businessindustryreports.com/buy-now/253572/single .

Product Type Segmentation

1 DNA

2 Live Attenuated Virus

3 NonReplicating Viral Vecto

4 Protein Subunit

5 RNA

Industry Segmentation

1 Treatment

2 Prevention

Big Medical Industry News:

Moderna (March 16, 2020) - Moderna Announces First Participant Dosed in NIH-led Phase 1 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus - Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the first participant has been dosed in the Phase 1 study of the Company's mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2). This Phase 1 study is being conducted by the National Institutes of Health (NIH) under its own Investigational New Drug (IND) application.

mRNA-1273 is an mRNA vaccine against SARS-CoV-2 encoding for a prefusion stabilized form of the Spike (S) protein, which was selected by Moderna in collaboration with investigators from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), a part of NIH. Manufacture of the first clinical batch was funded by the Coalition for Epidemic Preparedness Innovations (CEPI).

The Phase 1 study is evaluating the safety and immunogenicity of three dose levels of mRNA-1273 (25, 100, 250 ?g) administered on a two-dose vaccination schedule, given 28 days apart. A total of 45 healthy adults will be enrolled in the study. Participants will be followed through 12 months after the second vaccination. The primary objective is to evaluate the safety and reactogenicity of a two-dose vaccination schedule of mRNA-1273. The secondary objective is to evaluate the immunogenicity to the SARS-CoV-2 S protein.

"This study is the first step in the clinical development of an mRNA vaccine against SARS-CoV-2, and we expect it to provide important information about safety and immunogenicity. We are actively preparing for a potential Phase 2 study under our own IND," said Tal Zaks, M.D., Ph.D., Chief Medical Officer at Moderna. "We are grateful to NIH for their ongoing collaboration and to CEPI for funding the initial manufacturing of mRNA-1273 and are proud to be included with the many companies, worldwide health agencies and NGOs working on a possible response to the novel coronavirus outbreak."

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/253572 .

Major Points in Table of Contents:

Global Covid-19 Vaccine Market Report 2020

1 Covid-19 Vaccine Product Definition

2 Global Covid-19 Vaccine Market Manufacturer Share and Market Overview

3 Manufacturer Covid-19 Vaccine Business Introduction

4 Global Covid-19 Vaccine Market Segmentation (Region Level)

5 Global Covid-19 Vaccine Market Segmentation (Product Type Level)

6 Global Covid-19 Vaccine Market Segmentation (Industry Level)

7 Global Covid-19 Vaccine Market Segmentation (Channel Level)

8 Covid-19 Vaccine Market Forecast 2020-2025

9 Covid-19 Vaccine Segmentation Product Type

10 Covid-19 Vaccine Segmentation Industry

11 Covid-19 Vaccine Cost of Production Analysis

12 Conclusion

................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.